What should be administered to a patient diagnosed with a hemorrhagic CVA according to protocol?

In the case of a hemorrhagic cerebrovascular accident (CVA), the primary concern is to manage the bleeding and prevent further complications. Administering heparin infusion, while typically used in the management of thrombotic strokes, does not apply here since heparin is usually indicated for conditions like deep vein thrombosis or pulmonary embolism. In the context of a hemorrhagic stroke, the standard protocol does not involve anticoagulation but rather focuses on stabilizing the patient and managing blood pressure.

Typically, IV fluids may be given to ensure hydration and maintain blood pressure, but they do not directly address the pathology associated with a hemorrhagic CVA. Options involving thrombolytic therapy and oral anticoagulants would further exacerbate bleeding risks, which is contraindicated in cases of hemorrhagic strokes.

In such scenarios, close monitoring and symptomatic management can be critical, but obtaining a stable environment for the patient should be the priority rather than administering medications that would increase bleeding risk. Therefore, option B aligns best with managing the risks associated with this type of stroke.